Speaker #0Nominations open for the CAP's Meritorious Service Awards, free cancer screenings come to Jackson, Mississippi this April, and new insights shed light on how pathologists are tackling difficult-to-diagnose cancer cases. Coming up next.
This is Path News Network Daily Edition. From the College of American Pathologists,
I'm Stevon Burrell. It's Thursday, February 5th, and here are the latest headlines.
Recognition of service remains a key part of strengthening the pathology community. As nominations open for the 2026 CAP Meritorious Service Awards Program, the organization is also highlighting the impact of past honorees. One of last year's Pathology Advancement Award recipients, CAP member Dr. Matthew G. Hanna, said, This recognition is a meaningful affirmation of the work done to advance pathology. I am grateful to the CAP for its continued commitment to innovation and excellence in our field, and I share this award with the colleagues and mentors who have supported me along the way. Nominations for the 2026 awards are open through March 16th,
And a one-day opportunity for early cancer detection is coming to Jackson, Mississippi. On April 11th, the University of Mississippi Medical Center and Research Institute, in partnership with the CAP, will host a See, Test & Treat event. They'll offer free cancer screenings for uninsured and underinsured men and women. The event will include screenings for cervical, breast, oral, and lung cancer, with clinicians on site to review results and discuss next steps. Bethany Sabins, a nurse practitioner in gynecologic oncology at UMMC, says, When cancer is detected early before it has spread, outcomes are improved. Registration opens February 9th. Eligibility is determined through an online application or by phone. You'll find details at the link in today's show notes.
When cancer cases resist clear classification, molecular testing is becoming an essential diagnostic tool. In a recent Pathology News article, CAP members Dr. Jie-Fu Chen and Dr. JinJuan Yao examine how genomic, transcriptomic, and epigenetic profiling can help pathologists navigate difficult-to-classify tumors, including cancers of unknown primary. While histology and immunohistochemistry remain foundational, the authors explain that molecular testing can offer critical additional insight when conventional approaches fall short. Dr. Jin says, quote, When faced with a difficult-to-classify tumor, Molecular testing may be able to suggest the potential tumor type or primary site, which will inform the clinical management plan. As molecular technologies advance, expert interpretation remains central to accurate diagnosis and patient care.
And finally, a hospital laboratory in Illinois is being recognized for meeting national standards in laboratory quality and safety. OSF St. Anthony's Health Center Laboratory has earned reaccreditation from the CAP following a recent on-site inspection. Inspectors reviewed quality control procedures, staff qualifications, equipment, safety programs, and management practices to confirm alignment with current best practices. Sarah Braunmeier, Laboratory Services Manager at OSF St. Anthony's Health Center, says, "The CAP's Laboratory Accreditation Program is an engaging, collaborative experience that fosters continuous improvement."
That's all we have for today. Check out the show notes for today's topics covered. You can find us on Apple Podcasts, Amazon Music, or Spotify. Subscribe on your favorite platform. Look for more news like this in our weekly newsletters, published every Tuesday and Thursday. We'll be back. Back tomorrow at 5 a.m. Eastern with more CAP News. For The Daily Edition, I'm Stevan Barel. Have a great day.
